Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026)

Catalyst Pharmaceuticals filings provide 8 years of Inventory Average readings, the most recent being $36.0 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 83.36% to $36.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $36.0 million, a 83.36% increase, with the full-year FY2025 number at $28.4 million, up 61.17% from a year prior.
  • Inventory Average hit $36.0 million in Q1 2026 for Catalyst Pharmaceuticals, up from $32.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $36.0 million in Q1 2026 to a low of $7.0 million in Q4 2022.
  • Median Inventory Average over the past 5 years was $17.8 million (2024), compared with a mean of $16.3 million.
  • Biggest five-year swings in Inventory Average: dropped 5.96% in 2022 and later surged 107.77% in 2024.
  • Catalyst Pharmaceuticals' Inventory Average stood at $7.0 million in 2022, then soared by 77.08% to $12.3 million in 2023, then surged by 60.29% to $19.8 million in 2024, then surged by 64.81% to $32.6 million in 2025, then increased by 10.59% to $36.0 million in 2026.
  • The last three reported values for Inventory Average were $36.0 million (Q1 2026), $32.6 million (Q4 2025), and $23.3 million (Q3 2025) per Business Quant data.